The Case for Personalized Medicine: Defining the Field and Envisioning the Future of Healthcare.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 299
- By:
- Publication type:
- Article
Works matching IS 21660166 AND DT 2014 AND VI 3 AND IP 5
Results: 15
1
2
Value-Based Insurance -- Not Such an Easy Sell.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 298
- Publication type:
- Article
3
Enthusiasm High for Anti-PD-1 Agents.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 296
- Publication type:
- Article
4
Bevacizumab Not Cost-Effective in Metastatic Colorectal Cancer.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 295
- Publication type:
- Article
5
Anti-PD-1 Antibodies in NSCLC and Renal Cell Carcinoma.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 294
- Publication type:
- Article
6
Ibrutinib Tops Ofatumumab as Second-Line Therapy for CLL.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 293
- Publication type:
- Article
7
Oncologists Want to Discuss Cost of Treatments With Patients but Believe They Are Not Well Equipped to Do So.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 292
- Publication type:
- Article
8
Less May Be More With Zoledronic Acid.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 291
- Publication type:
- Article
9
Federal Spending on Cancer Research and Access to Care Called Woefully Inadequate by ASCO President.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 290
- Publication type:
- Article
10
PSA Trend Analysis May Help Avoid Unnecessary Biopsies.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 287
- Publication type:
- Article
11
Improved Survival With Antiandrogen After ADT in Metastatic CRPC.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 286
- Publication type:
- Article
12
Blocking Immune Checkpoints in Metastatic Melanoma.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 275
- By:
- Publication type:
- Article
13
RAS and Colon Cancer: What You're Missing.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 264
- By:
- Publication type:
- Article
14
Personalized Medicine and Value: An Interview With Faculty at the Fourth Annual Conference of the Association for Value-Based Cancer Care.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 254
- Publication type:
- Article
15
PMO: Advancing the Practitioner's Ability to Provide Customized Care to Patients.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 5, p. 252
- By:
- Publication type:
- Article